We investigated 11 genes, namely, TSPAN15, TSPO, METTL9, CD276, TP53I11, SPINT1, TRABD2B, SPINT, WARS2, C9ORF116, and LBH, which might act as immunotherapy targets for HCC. Here, TSPAN15 is linked to hepatocellular carcinoma.